HBN CASSS Mentorship Program and Industry Sponsorship Program

W. Taylor Cottle, PhD Candidate, HBN President The Hopkins Biotech Network continues to work towards building its network with industry and local leaders in the Baltimore Biotech and Pharma space. Despite shutdowns, we have been hard at work organizing a new mentorship program in collaboration with the CASSS organization. This program will introduce Hopkins students […]

Hopkins Biotech Podcast

Roshan Chikarmane, Co-Director of Alumni Relations, Ph.D. Candidate at Johns Hopkins School of Medicine Curious about career opportunities for life science students in pharmaceuticals, biotechnology, consulting, venture capital, and other private sector industries? Want to find the find the career path best suited to your skills, values, and interests? Tune in to our introductory episode […]

“How children may be affected by misinformation about vaccines”

John Jones, M.S. Biotechnology Johns Hopkins University Alumnus In 1796, Edward Jenner devised a method to protect individuals from smallpox by using blisters of someone infected with cowpox to inoculate another person against the virus. This was the genesis of vaccine science. Since that time, the understanding of infectious disease and the mass development and […]

Innovation in American Healthcare in the Search for a Vaccine

 Tawny Hammett, M.S. Individualized Genomics & Health  Johns Hopkins University Alumna The COVID-19 pandemic is slowly starting to makes its way to a period of tenuous recovery, bringing a welcomed sigh of relief to those feeling pandemic fatigue. Though many uncertainties still lie ahead, states are cautiously opening back up, providing a small sense of […]

COVID-19 and mRNA Vaccines: Fundamentals and Therapeutic Potential

Yazmin I. Rovira Gonzalez, PhD, Johns Hopkins UniversityAlumna On May 18th 2020, Moderna, Inc. – a clinical-stage biotechnology company focused on mRNA technologies, including messenger RNA-based vaccines and therapies – announced their Interim Phase 1 results for their messenger RNA vaccine (mRNA-1273) against novel coronavirus SARS-CoV-2. But first, what is an mRNA vaccine and how […]